Tag: property portfolio

The acquisition by Heimar hf. ("Heimar" or the "Company") of all shares in Gróska ehf. (“Gróska”) and Gróðurhúsið ehf. (“Gróðurhúsið”) (the “Transaction”), which was initially announced on 23 April this year, has now been completed. 

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on continued momentum with United States Food and Drug Administration (FDA) regarding both accelerated approval pathway for Revascor^® (rexlemestrocel-L) in the treatment of patients with ischemic chronic heart failure with reduced ejection fraction (HFrEF) and inflammation, and label extension for Ryoncil^® (remestemcel-L-rknd) in adults with steroid refractory acute graft versus host disease (SR-aGvHD).

London, UK, June 09, 2025 (GLOBE NEWSWIRE) -- Binaryx, a fractional real estate investing platform, is announcing its move to commercial scale following a successful pilot phase. With $4.4 million in processed investments, with a second-by-second payment of dividends to investors, and 25 tokenized properties launched, Binaryx is contributing to the broader shift toward real estate tokenization — a market projected to unlock $16 trillion in value by 2030.

Image Description: Sidd Mahajan is the founder and managing director of Tulip Real Estate

New York, NY, June 07, 2025 (GLOBE NEWSWIRE) -- Goldstein Patent Law, a national leader in patent law, is happy to announce it has recently published a new article on How to patent an idea. Leveraging the expertise and nearly 30 years of experience from the founder of the law firm and principal patent attorney Rich Goldstein, the new insights answer the question, “Can a concept be patented?” and help to demystify IP rights, how to secure patent protection and how intellectual property attorneys can help navigate the process.

Heimar hf. ("Heimar") has finalized its acquisition of all shares in Tryggvagata ehf., as previously announced on 20 February 2025. The sellers are MF2 hs. and Laxamýri ehf. The purchase price was settled in full through a combination of cash payment and assumption of debt. 

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine –

TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- Firm Capital Property Trust ("FCPT" or the "Trust"), (TSX: FCD.UN) is pleased to announce the voting results for its Annual and Special Meeting of unitholders ("Unitholders”) of Trust Units (“Units”) of the Trust held on June 5, 2025 (the “Meeting”).